Edgar Engleman, MD, medical director of the Stanford Blood Center, discusses his
research involving the use of a special type of white blood cell as a treatment
for cancer. Engleman, who is also a professor of pathology at the Stanford
School of Medicine, and his team of researchers have been interested in
dendritic cells, or DCs, which can provoke an immune response in the body.


http://bioisolutions.blogspot.com/2009/06/using-dendritic-cells-to-create-cancer\
.html

Cheers,
Julian Thomas
http://bioisolutions.blogspot.com/